Matthew Stork joins DP Medical as Chair of Board of Directors

Matthew has held leadership and board director roles within medtech, digital health, and clinical services for 25 years, including roles with Smith & Nephew, GE Healthcare, InHealth, and Canon Medical Systems.

A qualified pharmacist who was formerly chair of MiHealthcare, Matthew is a co-investor alongside the Foresight Group, which recently completed a £4.45 million investment in DP Medical, a deal that will enable new product launches and allow us to achieve our ambitious growth plans.

Matthew said: “DP Medical has a strong and capable leadership team that has delivered outstanding revenue growth in recent years, and it has a vision and plans for future growth.

“The company has a great mix of products, including innovative solutions that attract interest from leading clinicians with every-day offering to meet the broader requirements of clinical providers. The investment by Foresight is really positive and I have experience working with the company before; it will be a supportive, value-adding investor.”

As Chair, Matthew will lead the board in establishing a strategy that drives shareholder returns, while at the same time overseeing governance and ensuring stakeholder engagement, which will include caring for employees and customer satisfaction.

“DP Medical has a fantastic team with deep clinical knowledge, who care for each other, and who are focused on customer service,” said Matthew.

“We have an opportunity to grow the company considerably from a sound base. There is great potential for the company to increase sales of the existing products into more hospitals across the UK and Ireland and more sectors of the market.

“At the same time, we are in a period of great medtech innovation with more devices, surgical techniques, software solutions, and care pathways that can provide many new opportunities in the future for a nimble, capable, and focused business such as DP Medical to grow sales massively.”

DP Medical has achieved significant growth in the last five years, supported by growing contributions from our Irish operations.

The investment from Foresight, which has a strong track record in investing in healthcare, will enable us to drive growth through continued expansion in Ireland, increasing the size of the team across the UK, and introduce more innovative products to market.

Owen Pemberton, Managing Director at DP Medical, said: “This is an exciting time for DP Medical and we are delighted to have someone with Matthew’s experience and expertise joining as Chair to lead us through the next stages in the company’s growth and development.”